CAR T-cell therapy, a revolutionary technology originally developed for blood cancers, may also help in restoring the immune system in severe autoimm1
The campaign’s challenge was to collect 12,000 book reviews, and it exceeded its goal. A total of 15,399 reviews were received.
Immune checkpoint inhibitors are a type of immunotherapy against cancer that activates the immune system to attack tumour cells. Although it is quite1
The IDIBAPS Board of Governors has approved the creation of a new research group. The decision follows the scientific evaluation of the researchers –1
Trial TILs001, which is open to patients with metastatic triple-negative breast cancer, is the first study to assess the safety and efficacy of TILs1
